Status:
COMPLETED
Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty
Lead Sponsor:
Glaukos Corporation
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluation of intraocular pressure (IOP) lowering effect of two iStent stents versus a SLT procedure in subjects with open-angle glaucoma on one ocular hypotensive medication.
Detailed Description
Evaluation of intraocular pressure (IOP) lowering effect of two iStent stents versus a SLT procedure in subjects with open-angle glaucoma on one ocular hypotensive medication.
Eligibility Criteria
Inclusion
- Phakic study eye or study eye with a posterior chamber intraocular lens (PC-IOL)
- Primary open-angle glaucoma (including pseudoexfoliative)
Exclusion
- Aphakic or pseudophakic with anterior chamber IOLs (AC-IOLs) (study eye)
- Prior stent implantations (study eye)
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 9 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01444105
Start Date
September 1 2011
End Date
April 9 2019
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S.V. Malayan Ophthalmological Center
Yerevan, Armenia, 0001